miR-23b-5p was described as acting as a tumor suppressor in a variety of cancers, most importantly by inhibiting the FOXC1 gene, a known oncogene with important roles in signal transduction and tumor progression [104,105]. This evidence concerns the gene FOXC1 and neoplasm.